13D Filing: Armistice Capital and Cerecor Inc (CERC)

Page 1 of 10

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Armistice Capital 0 3,360,000 0 3,360,000 3,360,000 23.9%
Armistice Capital Master Fund, Ltd 0 3,360,000 0 3,360,000 3,360,000 23.9%
Steven Boyd 0 3,360,000 0 3,360,000 3,360,000 23.9%

Follow Steven Boyd's Armistice Capital

Page 1 of 10 – SEC Filing


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.1)*
Cerecor Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
15671L109
(CUSIP Number)
Evan Thomas
c/o Armistice Capital LLC
510 Madison Avenue
22nd Floor
New York, NY 10022
Telephone Number: 212-231-4930
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
May 11, 2017
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d‑1(f) or 240.13d-1(g), check the following box [_].
*          The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

Follow Avalo Therapeutics Inc. (NASDAQ:AVTX)

Page 1 of 10